Loading...
Loading...
- Barclays lowered Vertex Pharmaceuticals Incorporated VRTX price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.
- Roth Capital cut the price target on Ocugen, Inc. OCGN from $10 to $6. Ocugen shares rose 2.8% to $6.88 in pre-market trading.
- Wells Fargo raised Signet Jewelers Limited SIG price target from $57 to $70. Signet Jewelers shares rose 1.1% to $70.35 in pre-market trading.
- Rosenblatt reduced the price target on Snowflake Inc. SNOW from $270 to $265. Snowflake shares fell 3.5% to $240.00 in pre-market trading.
- Credit Suisse boosted Celsius Holdings, Inc. CELH price target from $57 to $78. Celsius Holdings shares rose 2.8% to $63.50 in pre-market trading.
- Goldman Sachs raised the price target on Canadian Natural Resources Limited CNQ from $38 to $44. Canadian Natural Resources shares fell 0.2% to close at $36.97 on Thursday.
- RBC Capital lifted the price target for Prothena Corporation plc PRTA from $28 to $50. Prothena shares fell 1.2% to $44.00 in pre-market trading.
- JP Morgan cut MorphoSys AG MOR price target from $32 to $24. MorphoSys shares fell 4.3% to $20.58 in pre-market trading.
- B of A Securities boosted the price target for Embraer S.A. ERJ from $8 to $20. Embraer shares rose 4.3% to $16.40 in pre-market trading.
- Raymond James boosted FS Bancorp, Inc. FSBW price target from $72 to $77. FS Bancorp shares fell 2.3% to close at $69.48 on Thursday.
Check out other big price target changes here
Loading...
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in